Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed vs Free Combination of Atorvastatin, Perindopril, and Amlodipine (FILIP)
NCT03047538Phase 4Withdrawn
- Sponsor
- Charles University
- Start
- Sep 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atorvastatin, perindopril and amlodipine in hypertension (HTN) and dyslipidemia (2 arms), sponsored by Charles University. Primary endpoints: Blood pressure control at 16 weeks and Lipids control at 16 weeks. Planned start Sep 2017; status: withdrawn.
02
Drugs
atorvastatinperindoprilamlodipine
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT03047538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03047538.